Get started
ZZZ

Zogenix, Inc. 2.75% 01-OCT-2027

No trades
See on Supercharts
Overview
Analysis

ZGNX5278061 chart


Full chart

Key terms


Outstanding amount
‪18.57 M‬ USD
Face value
1,000.00 USD
Minimum denomination
1,000.00 USD
Coupon
2.75% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
−1.43%
Maturity date
Oct 1, 2027
Term to maturity
2 years

About Zogenix, Inc. 2.75% 01-OCT-2027


Issuer
Zogenix, Inc.
Sector
Health Technology
Industry
Pharmaceuticals: Major
Home page
zogenix.com
Issue date
Nov 7, 2021
FIGI
BBG00XKLQ2Z7
Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA.

ZGNX5278061 analysis


Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.

See how Zogenix, Inc. is moving with its highest-yielding bonds.